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1 Introduction
The average human diet consists of a combination of carbohydrates (50%) and lipids
(fats, 30%), delivered as meals in a discontinuous manner. Human physiology has
evolved mechanisms that enable it to cope with discontinuities in the supply of and the
demand for energy. In the healthy state, the organs respond to plasma (blood) nutrient
levels through a series of well-controlled mechanisms, such that energy is stored at times
of surplus and is released at times of requirement. Efficient handling of post-prandial
nutrients results in a minimal glucose response, appropriate insulin secretion, suppression
of stored lipid mobilization and oxidation, along with activation of energy uptake into
tissues for storage. Thus healthy carbohydrate and lipid metabolism is dependent upon
the coordinated regulation of the organs governing carbohydrate and lipid fluxes, namely
the brain, pancreas, liver, skeletal muscle and adipose tissue.
In lean, healthy individuals there is a high reliance upon lipid oxidation with high rates of
fatty acid uptake during fasting conditions. In addition healthy tissue displays metabolic
flexibility, that is, it is capable of switching between lipid oxidation in the fasted state
and the suppression of lipid oxidation in favour of increased glucose uptake, oxidation
and storage during the fed state [2]. In obese subjects, there is a lesser reliance on lipid
and a greater reliance on glucose oxidation in both the fed and the fasted states.
This reduction in the ability to switch between fuel types in obese subjects is
characteristic of insulin resistant states such as obesity and Type 2 diabetes [6]. Subjects
with such conditions exhibit failure to increase lipid oxidation in the fasted state and
failure to suppress lipid oxidation in response to increased insulin levels.
In skeletal muscle of a lean, healthy individual, insulin strongly suppresses lipid oxidation
during insulin-stimulated (fed) conditions and induces a high reliance upon glucose
oxidation, whereas in skeletal muscle of an obese, insulin resistant individual, there
is less stimulation of glucose oxidation by insulin and blunted suppression of lipid
oxidation. Thus, in the skeletal muscle of obese, insulin resistant individuals, there
is a constricted range in switching between lipid and glucose oxidation compared to the
dynamic switching observed in lean, healthy individuals. This constrained homeostatic
adjustment to the transitions between fasting and insulin-stimulated conditions in obese,
insulin resistant individuals has been described as ‘metabolic inflexibility’ of skeletal
muscle [13, 7].
We aim to develop a mathematical model of skeletal muscle fuel utilization, that will
enable an investigation of the dynamics of skeletal muscle glucose and lipid handling in
response to a meal. The model should:
• initially aim to reproduce data that describe the effect of an individual’s fat mass
and insulin sensitivity on the preference for fat/glucose oxidation in myocytes
(metabolic flexibility of muscle cells);
• aim to simulate the effects of different rates of delivery of glucose and lipid to
skeletal muscle in the fed and fasted states;
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• allow us to investigate the effects of varying glucose and fatty acid availability on
preference for fat oxidation in individuals with different phenotypes (varied body
mass index, fat mass and insulin sensitivity).
In Section 2, we construct a model of a muscle cell, including
• the transport of glucose and lipids from the blood stream into the cells,
• the cell’s internal storage of glucose as glycogen, and
• the glucose and lipid oxidation processes.
We show that the system has a physically-relevant steady-state solution (Section 2.2).
When nondimensionalising the model (Section 2.3) to make the numerical solutions more
straightforward we obtain a number of constraints on the relative sizes of parameter
groups (Section 2.4). Section 3 contains a description of the results of our numerical
solutions, and conclusions are drawn in Section 4.
2 Metabolism
The metabolic system is complicated and involved. For the purposes of the problem
to be studied herein, it is not necessary (nor, indeed, is it helpful) to consider all the
interactions known. Therefore we consider a simplified system (shown in Figure 1).
The main currency of energy in cells is adenosine triphosphate (ATP). Energy is released
from ATP upon removal of a phosphate from ATP, forming ADP (adenosine diphosphate)
via the enzyme-mediated reaction
ATP + H2O → ADP + HPO4 +ΔE, (1)
where ΔE denotes the amount of energy released, and HPO4 is the phosphate group
removed from ATP. A second phosphate group can be lost from ADP, yielding adenosine
monophosphate (AMP) and releasing further energy. To avoid energy depletion, cells
need to activate processes which take fuel into cells and convert AMP and ADP to
ATP. The processes of glucose and fat oxidation produce ATP. It is the purpose of this
report to investigate the interaction between these two ATP resynthesising, fuel oxidation
pathways. For simplicity, we focus on AMP, and its conversion to ATP, and we denote by
P the concentration of a chemical species which controls the activity of this pathway. By
‘activity’ we mean the flux of material through the pathway. We expect P to be strongly
correlated with the concentration of AMP. The simplest option is to simply take P as
the concentration of AMP; however, future work may identify an enzyme which more
conveniently describes the activity of the AMP → ATP pathway. The variable P will
be large when muscle cells have recently done work and, as cells recover and replenish
their ATP levels, P will decrease. We are interested in the whole process from feeding
through digestion of an (evening) meal, to the fasted state which is typically reached
about 12 hours later.
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Figure 1: Diagram of the biochemical reaction network modelled in the rest of this paper.
2.1 The model
We construct a compartmental model of the system illustrated in Figure 1 by formulating
ordinary differential equations for the spatially-averaged concentrations of glucose,
glycogen, insulin, free fatty acids (FFA) and triglycerides (TG), both systemically (in
the blood supply) and the muscle cells.
The processes included in Figure 1 can be represented by the chemical processes
{liver/gut} FG(t)−→ Gb kG−→ Gm, Gb + I kGkGI−→ Gm + I,
{adipose tissue/gut} FA(t)−→ Ab kA−→ Am,
{adipose tissue/gut} FT (t)−→ Tb kT−→ Am, Tb + I kT kTI−→ Am + I.
(2)
These represent the transport of glucose, free fatty acids and triglycerides from the gut,
liver and adipose tissue through the blood plasma to muscle cells. Some processes are
‘passive’ in that they simply rely on concentration gradients, and have rates denoted by
FG, kG, etc.; other processes are accelerated by the presence of hormones, such as insulin
(I): these are denoted by acceleration factors kGI and kTI .
Once inside the cell, glucose can be stored as glycogen, which we denote by the chemical
process Gm  Ym. To make this apparently simple process more realistic we make the
storage and release rates depend both on the insulin concentration (I) and the amount
of work done recently by cells (which we assume can be described by P ). Hence
Gm ⇀ Ym rate = kY
(
1 + kY II
1 + kY PP
)
, (3)
Gm ↽ Ym rate =
kCPP
1 + kCII
. (4)
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Finally, we describe the oxidation of glucose and fatty acids. We assume the former
occurs only in the presence of insulin, but then occurs rapidly (insulin acting as a
catalyst), while the latter occurs more slowly, but does not require a catalyst, that
is
P + Gm + I
MG−→ ATP + I, (5)
P + Am
MA−→ ATP. (6)
We model the flow of the nutrients (glucose, fatty acids and triglycerides) into the blood
stream by the functions
FG(t) = βG +
FθGt
B2G
e−t
2/2B2G , (7)
FA(t) = βA +
FθAt
B2A
e−t
2/B2A , (8)
FT (t) = βT +
FθT t
B2T
e−t
2/B2T , (9)
which will appear as ‘forcing’ terms in differential equations derived later. These
functions have the form of a linear growth followed by a smooth peak and rapid decay.
The position of the maximum and total area under the curve can be varied by judicious
choice of B∗ and θ∗. Here, the B∗ parameters denote the rate at which the nutrients are
released from a meal, the parameters θ∗ describe the relative proportion, in a diet, of
each type of nutrient, and F is a measure of the total diet, such that FθG is a glucose
concentration, and FθA and FθT are fat concentrations. The β∗ parameters denote a
background (basal) rate of supply to the blood stream from the liver and from adipose
tissue.
The functions (7)–(9) are inputs to the equations governing the concentrations of glucose,
Gb, free fatty acids, Ab, and triglycerides, Tb, in the blood plasma:
α
dGb
dt︸ ︷︷ ︸
rate of change of
blood glucose conc.
= FG(t)︸ ︷︷ ︸
source of
glucose from
gut & liver
− SGGb︸ ︷︷ ︸
use of glucose
by rest of
body
− kG(1 + kGII)Gb,︸ ︷︷ ︸
uptake of glucose
by muscle cells (incl.
control by insulin)
(10)
α
dAb
dt︸ ︷︷ ︸
rate of change
of blood fatty
acid conc.
= FA(t)︸ ︷︷ ︸
source of fatty
acids from gut
& adipose tissue
− SAAb︸ ︷︷ ︸
use of fatty acids
by rest of body
− kAAb,︸ ︷︷ ︸
uptake of
fatty acids by
muscle cells
(11)
α
dTb
dt︸ ︷︷ ︸
rate of change
of blood
triglyceride conc.
= FT (t)︸ ︷︷ ︸
source of
triglycerides from
gut & adipose tissue
− STTb︸ ︷︷ ︸
use of
triglycerides by
rest of body
− kT (1 + kTII)Tb.︸ ︷︷ ︸
uptake of
triglycerides by
muscle cells
(12)
We assume that each nutrient is utilised by other tissues in the body, at rates SG, SA,
ST , as well as being transported into muscle cells as shown in Figure (1) at rates kG, kA,
kT .
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We introduce the parameter α which is defined as the ratio of the blood volume to the
muscle volume. Due to Gb and Gm both being concentrations, and the blood volume
being less than the muscle volume, as molecules cross from the plasma into muscle cells
the decrease in concentrations in the blood volume is greater than the increase in the
muscle volume. Similar differences occur between Ab and Am, and Tb and Am.
Whilst fatty acids cross into cells passively, the transport of glucose is controlled by
insulin, and that of triglycerides is more complex still. Triglycerides (TG) are first
converted into fatty acids in an enzyme-catalyzed reaction prior to being taken up into
cells. For simplicity, we assume that insulin controls this process, whereas in reality
there is some debate as to the importance of insulin/other hormones in the uptake of
plasma TG into skeletal muscle. In later work we aim to investigate the evidence for
the control of TG uptake and to describe this pathway in more detail by modelling how
blood TG concentration depends on diet, and insulin, etc. The insulin-dependencies are
denoted by the constants kGI and kTI . It is known that insulin controls the uptake of
triglycerides into some cells in the human body, but it has not yet been confirmed that it
is the controlling hormone for triglyceride uptake by muscle cells. The enzyme lipoprotein
lipase regulates the uptake of triglycerides into muscle cells, and this is controlled by some
hormone, which we postulate to be insulin, and hence introduce the rate parameter kTI .
Later, we can assume that insulin is not involved, and so put kTI = 0.
The insulin concentration is governed by the concentrations of glucose and fatty acids
in the blood, along with a rate of decay, λI ; its concentration is determined from
dI
dt︸︷︷︸
rate of change
of blood
insulin conc.
= kIGGb︸ ︷︷ ︸
creation of
insulin due to
blood glucose
+ kIAAb︸ ︷︷ ︸
creation of
insulin due to
blood fatty acids
− λII.︸︷︷︸
natural decay
of insulin
(13)
Inside muscle cells, glucose can be converted into glycogen – a short-term energy store,
which we denote by Ym. This process is controlled by insulin, I, which binds to receptors
on the surface of muscle cells and can thence influence processes occurring inside the
cells. Furthermore, we assume that the reversible conversion of glucose to glycogen is
influenced by the chemical species we denote by P , which is strongly correlated to the
concentration of AMP.
We assume that P is created by physical activity at a rate μ, and is degraded naturally
at some rate λP ; the dynamics we are primarily interested in are the switching between
the oxidation of P by glucose and by fatty acids, and how the switch between the two
occurs. We assume that glucose oxidation occurs rapidly in the presence of insulin and
P . Although enzymes do regulate fatty acid oxidation, we do not detail them here;
instead we assume that no enzyme is required to activate this process, and that fatty
acid oxidation occurs slowly in the presence of P . The rates of the glucose and fatty
acid oxidation processes are denoted MG and MA respectively; γg and γa are the number
of P molecules used in the oxidation of a glucose and a fatty acid molecule respectively.
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The concentrations in muscle cells evolve according to
dGm
dt︸ ︷︷ ︸
rate of change
of muscle
glucose conc.
= kG(1 + kGII)Gb︸ ︷︷ ︸
insulin-controlled uptake
of glucose into muscle cells
− MGPIGm︸ ︷︷ ︸
insulin-mediated
oxidation of glucose
− kY
(
1 + kY II
1 + kY PP
)
Gm︸ ︷︷ ︸
storage of glucose
as glycogen
+
kCPPYm
1 + kCII
,︸ ︷︷ ︸
conversion of glycogen
back into glucose
(14)
dYm
dt︸︷︷︸
rate of change
of muscle
glycogen conc.
= kY
(
1 + kY II
1 + kY PP
)
Gm︸ ︷︷ ︸
storage of glucose
as glycogen
− kCPPYm
1 + kCII
,︸ ︷︷ ︸
conversion of glycogen
back into glucose
(15)
dAm
dt︸ ︷︷ ︸
rate of change
of muscle
fatty acid conc.
= kAAb︸ ︷︷ ︸
uptake of
fatty acids
from blood
+ kT (1 + kTII)Tb︸ ︷︷ ︸
insulin-controlled
uptake of triglycerides
from blood
− MAAmP,︸ ︷︷ ︸
oxidation of
fatty acids
(16)
dP
dt︸︷︷︸
rate of change
of muscle
AMP conc.
= μ︸︷︷︸
production
of AMP
− λPP︸︷︷︸
decay
of AMP
− γaMAAmP︸ ︷︷ ︸
oxidation of
fatty acids
− γgMGPIGm.︸ ︷︷ ︸
oxidation of
glucose
(insulin-dependent)
(17)
We have neglected the internal reversible conversion of fatty acids into triglycerides which
is equivalent to the storage of glucose as glycogen. We do not expect these effects to
significantly alter the behaviour of the model, and including them would only complicate
further an already involved system of equations.
The eight coupled nonlinear differential equations (10)–(17) represent the flows in Figure
1. There are 36 free parameters, which are listed in Table 1. Note that there are five
flows in this diagram that are regulated by insulin. Four (namely the entry of glucose
into the muscle cell, the entry of triglycerides into the cell, the production of ATP from
glucose, the conversion of glucose to glycogen in the cell) have a positive dependence on
insulin and one (namely the inhibition of the conversion of glycogen back into glucose)
a negative dependence.
The process of determining the parameters listed in Table 1 (including references for
each parameter found) was started during the study group, but not completed. Whilst
important, this is a longer-term goal since, in the literature, there is debate over
precise values for the parameters, and determining what data actually represent requires
extensive numerical simulation, which is beyond the timescale of this write-up. Some
of the data have been found in [1, 3, 4, 5, 7, 8, 9, 10, 11, 12, 15]. In Section 3, we use
example data to illustrate the types of behaviour that can be exhibited by the system.
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Parameter Description Value
MG Glucose oxidation rate constant 0.97mg kg
−1min−1
MA FFA oxidation rate constant 1.8 or 1.1mg kg
−1min−1
kY glycogen synthesis rate constant (basal) 0
kY I glycogen synthesis constant (insulin stimulated)
kY P glycogen syntehsis constant (AMP inhibited)
kT muscle triglyceride uptake constant (basal)
kTI muscle triglyceride uptake const. (insulin stimulated) 0
kG muscle glucose uptake constant (basal) 18.6μmol/kg muscle/min
kGI muscle glucose uptake constant (insulin stimulated)
kCP glycogenolysis constant (AMP stimulated)
kCI glycogenolysis constant (insulin inhibited)
SA body FFA consumption rate (release pre+post feed) 1/3/hr=10μmol/kg body
SG body glucose consumption rate
ST body triglyceride consumption rate 13.9 mg/h
μ AMP (P) creation rate ([AMP] = 0.1 – 6 μ M)
λI insulin degradation rate plasma
1
2
= 6 mins
kIG insulin production rate
kIA insulin production rate
kA muscle FFA uptake rate constant
βA basal FFA production rate
βT basal triglyceride production rate
βG basal glucose production rate 2.7 mg/kg/min
τA delay from feeding to FFA reaching blood plasma 3 hrs
τT delay from feeding to triglycerides reaching blood 3 hrs
τG delay from feeding to glucose reaching blood plasma 10 mins
kFA rate of uptake of FFA to blood 2/3 hr
−1
kFG rate of uptake of glucose to blood 1/3 hr
−1
kFT rate of uptake of triglycerides to blood hr
−1
θG amount of carbohydrates in diet 0.55
θA amount of FFA in diet 0.15
θT amount of triglyceride in diet 0.15
F total calorific content of diet
α plasma volume/skeletal muscle volume 0.17
γa number of P molecules used when FFA is oxidised
γg number of P molecules used when glucose is oxidised 32
λP degradation of P in absence of any other process
Table 1: Summary of parameters in the model.
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2.2 The steady-state
At large-times, by which we mean about 12 hours after a meal, the functions FG, FA and
FT in (7)–(9) approach the constants βG, βA and βT respectively. The equations (10)–
(17) then have a steady-state solution. We denote steady-state values by a superscript
‘∗’.
We first solve (10)–(12) to find
A∗b =
βA
kA + SA
, T ∗b =
βT
ST + kT (1 + kTII∗)
, G∗b =
βG
SG + kG(1 + kGII∗)
. (18)
Equation (13) is a quadratic which determines the insulin level; this has the solution
I∗ =
1
2λkGkGI
(
−bi +
√
b2i + 4λkGkGIci
)
, (19)
where
bi = λ(SG + kG)− kIAβAkGkGI
kA + SA
, ci = kIGβG +
kIAβA(SG + kG)
kA + SA
. (20)
Since the quadratic has the form λkGkGII
2 + biI − ci with λkGkGIci > 0 the two roots
are both real, with one being positive (19) and the other negative.
The system can thus be decoupled into two subsystems which can be solved
independently: one for Gb, Ab, Tb, I whose solution drives the secondary system for
Am, Gm, Ym and P . The equations (14)–(16) for Gm, Ym, Ab are solved next, with
solutions
G∗m =
βGkG(1 + kGII
∗)
MGP ∗I∗(SG + kG(1 + kGII∗))
, (21)
Y ∗m = kY Gm
(
1 + kY II
∗
1 + kY PP ∗
)(
1 + kCII
∗
kCPP ∗
)
, (22)
A∗m =
1
P ∗MA
[
kAβA
kA + SA
+
βTkT (1 + kTII
∗)
ST + kT (1 + kTII∗)
]
. (23)
All these can be substituted into (17) to find
P ∗ =
μ− μc
λP
, μc :=
γGβGkG(1 + kGII
∗)
SG + kG(1 + kGII∗)
+
γAβAkA
kA + SA
+
γAβTkT (1 + kTII
∗)
ST + kT (1 + kTII∗)
. (24)
Since all these variables are concentrations, they must be positive, and to ensure that
P ∗ > 0, we are left with the constraint μ > μc, where μc is defined in (24), and I∗ is
given by (19)–(20).
We are fortunate indeed that, given such a complicated system of equations, it is possible
to find a steady-state solution in explicit form, and furthermore, through the process of
direct solution, to show that such a state is unique.
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2.3 Non-dimensionalisation
Before attempting a numerical solution of the equations (10)–(17) to investigate the
kinetics of the system following a meal, we nondimensionalise the equations. To
nondimensionalise the system, we rescale each variable by its steady-state value (18)–
(24), and introduce new, nondimensional, variables denoted with hats, via
Ĝb =
Gb
G∗b
, Âb =
Ab
A∗b
, T̂b =
Tb
T ∗b
, Î =
I
I∗
, (25)
Ĝm =
Gm
G∗m
, Ŷm =
Ym
Y ∗m
, Âm =
Am
A∗m
, P̂ =
P
P ∗b
, t =
αG∗b
βG
t̂. (26)
We choose the timescale to be that of the equilibration of the blood glucose level (Gb).
At large times, FG(t) ∼ βG, so (10) has the form αG˙b = βG − βGGb/G∗b , giving the
characteristic timescale αG∗b/βG. This is relatively fast, when compared to the rates of
change of fat levels in the blood. Values for the steady-state concentrations are available
in the literature, some being listed in Table 2.
Parameter Description Value
G∗b plasma glucose 85 mg/dl
A∗b plasma FFA 140 μM
T ∗b plasma triglyceride 68 mg/dl
I plasma insulin 10 μU/ml or 72 mIU/l
Y ∗m fasted muscle glycogen content 68 μM or 80 nmol/l muscle
muscle TG 50 mmol/kg dry weight
G∗m muscle glucose
A∗m muscle FFA
P ∗ muscle AMP
Table 2: Values of steady-state concentrations determined from published experimental
data. The insulin units can be converted to standard dimensions by noting that 1 μmol
per ml = 1 mmol per l = 6 pmol per l. We expect a larger value for the glycogen content.
Also, this should be quoted in units of mmol of glucose equivalent per kg fresh weight.
Hopefully a more detailed search of the literature will yield such a value.
The forcing functions FG(t), FA(t) and FT (t) and their associated parameters are
nondimensionalised as follows
F̂G
(
t̂
)
= 1 +
k̂FGt̂
τ̂G
e−t̂
2
/2τ̂2G , k̂FG =
FθG
BGβG
, τ̂G =
BGβG
αG∗b
, (27)
F̂A
(
t̂
)
= 1 +
k̂FAt̂
τ̂A
e−t̂
2
/2τ̂2A , k̂FA =
FθA
BAβA
, τ̂A =
BAβG
αG∗b
, (28)
F̂T
(
t̂
)
= 1 +
k̂FT t̂
τ̂T
e−t̂
2
/2τ̂2T , k̂FT =
FθT
BTβT
, τ̂T =
BTβG
αG∗b
. (29)
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Here we note that θG, θA, θT are already nondimensional, being proportions of the diet
composed of carbohydrates, fatty acids and triglycerides respectively. The θ∗ values do
not sum to one since typical diets include significant amounts of protein, which we are
neglecting in the current model.
We obtain the nondimensional equations (in which, for convenience, we have dropped
the hats on the variables)
dGb
dt
= FG −Gb + β0Gb(1− I), (30)

ab
dAb
dt
= ψa(FA −Ab), (31)

t
dTb
dt
= ψT (FT − Tb) + γtβ4(1− I)Tb, (32)

i
dI
dt
= β6(Gb − I) + β7(Ab − I), (33)

g
dGm
dt
= μg(Gb − PIGm)− β0Gb(1− I)
−β2
(
(1 + γp)
(1 + γpP )
(1 + γyI)
(1 + γy)
Gm − (1 + γI)
(1 + γII)
PYm
)
, (34)

am
dAm
dt
= μa(Ab − AmP )− β4(Ab − Tb + γt(Ab − ITb)), (35)

y
dYm
dt
= β2
(
(1 + γp)
(1 + γpP )
(1 + γyI)
(1 + γy)
Gm − (1 + γI)
(1 + γII)
PYm
)
, (36)

p
dP
dt
= μp(1− P ) + γgμgP (1− IGm) + γaμaP (1−Am). (37)
Here, the new (dimensionless) parameters are given by
β0 =
kGkGII
∗G∗b
βG
, β2 =
kCPP
∗Y ∗m
βG(1+kCII∗)
, β4 =
kTT
∗
b
βG
, β6 =
kIGG
∗
b
βG
, β7 =
kIAA
∗
b
βG
,
(38)
γp = kY PP
∗, γI = kCII∗, γy = kY II∗, γt = kTII∗, (39)
μp =
μ
βG
, μg =
MGP
∗I∗G∗m
βG
, μa =
MAP
∗A∗m
βG
, ψa =
βA
βG
, ψT =
βT
βG
, (40)

ab =
A∗b
G∗b
, 
t =
T ∗b
G∗b
, 
g =
G∗m
αG∗b
, 
am =
A∗m
αG∗b
, 
y =
Y ∗m
αG∗b
, 
p =
P ∗
αG∗b
, 
i =
I∗
αG∗b
,
(41)
the last line defines the various timescales relative to the timescale for the rate of
change of the blood glucose concentration (Gb). We note that only insulin responds
on a faster timescale (
i < 1 while all the other 
∗ parameters are greater than unity).
The values adopted for the non-dimensional parameters are given in Table 3. Here we
have introduced an additional, nondimensional, parameter, σ, which describes the insulin
sensitivity. Several other parameters depend on σ, and changing the single parameter
σ allows us to alter the sensitivity of the processes which depend on insulin, and hence
model the response of individuals with a variety of insulin sensitivities.
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Parameter Value Description
σ 1 Insulin sensitivity (σ < 1 for insulin-insensitive)
β0 0.1 Insulin-controlled takeup of glucose from plasma to cells
β2 1 Rate of glucose-glycogen conversion
β4 0.001σ Insulin-activated rate of transport of TG into muscle cells
β6 0.1σ Influence of blood glucose on insulin
β7 0.01σ Influence of blood FFA on insulin
γp 1 P -inhibited conversion of glucose to glycogen
γI 1 Insulin-inhibition of glycogen conversion to glucose
γy 1 Insulin-activated conversion of glucose into glycogen
γt 0 Insulin-controlled takeup of plasma triglyceride into muslce
μp 4000 Rate of AMP creation
μg 0.3 Rate of glucose oxidation
μa 0.5 Rate of FFA oxidation
ψa 0.1σ Rate of uptake of FFA by muscle cells
ψT 0.1σ Rate of uptake of triglyceride by muscle cells

ab 1 Timescale for the evolution of blood fatty acids

t 1 Timescale for the evolution of plasma triglycerides

g 6/σ Timescale for the evolution of muscle glucose

am 1 Timescale for the evolution of muscle fatty acids

y 60/σ Timescale for the evolution of glycogen

p 1/σ Timescale for the evolution of AMP

i 0.01/σ Timescale for the evolution of insulin
γa 30 Number of P molecules used when FFA is oxidised
γg 30 Number of P molecules used when glucose is oxidised
τ̂G 0.5 timescale for digestion of glucose
τ̂A 2 timescale for digestion of FFA
τ̂T 2 timescale for digestion of triglycerides
k̂FG 120 nondimensional quantity of carbohydrate ingested
k̂FA 150 nondimensional quantity of FFA ingested
k̂FT 100 nondimensional quantity of triglycerides ingested
Table 3: List of nondimensional parameters, their interpretation, and values used to
produce the example results illustrated in Section 3. Note that timescales are measured
relative to the timescale for the evolution of the blood glucose level.
2.4 Constraints
The set of dimensionless parameter definitions (38)–(41) may not be optimal in terms of
reducing the number of parameters, but many of them are calculable from data published
in the literature.
The system of equations (30)–(37) highlights various additional constraints on the
parameters. Let us first consider equation (30). If I were to be small and FG constant,
we would still expect the blood glucose concentration Gb to approach a steady value.
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Similarly, in equation (32), with FT constant and I small, the system should asymptote
to a steady value of Tb. Hence we expect
β0 < 1, and ψT > γtβ4. (42)
The former simply implies that the steady-state supply of glucose into the bloodstream
should be larger than the insulin-controlled uptake rate from the bloodstream into muscle
cells. The latter implies that the supply of triglycerides from adipose tissue into the
bloodstream should be larger than the insulin-controlled uptake into muscle cells.
We still expect there to be a flow of glucose and fat from the bloodstream to the muscle
in order for the cells to have sufficient energy to stay alive and convert AMP to ATP.
From the top line of equation (34), for this to happen when I = 0, we require
μg > β0; moreover, μa > β4(1 + γt) (43)
arises in a similar fashion by considering the terms involving Ab in equation (35). Since
as t →∞, the fluxes of glucose and lipids through the network in Figure 1 do not decay
to zero, the resultant state can only be described as steady, and not an equilibrium.
From (37), requiring the steady-state P = 1 to be stable leads to
μp > γgμg + γaμa, (44)
this prevents the possibility of a blow-up in P if Am and/or Gm are below their steady-
state values. Physically this implies that the production rate of P should exceed the
sum of the destruction rates due to glucose and fatty acid oxidation.
2.5 Assessing metabolic flexibility
To consider metabolic flexibility, we need to measure how large a switch between glucose
oxidation and fatty acid oxidation can be achieved. Hence we define a quantity
SW =
μgPIGm
μaAmP + μgPIGm
=
μgIGm
μaAm + μgIGm
, (45)
which is the proportion of oxidation due to glucose. Clearly 0 ≤ SW ≤ 1. Since in (37),
we expect γgμg > γaμa, when glucose levels are high, we expect insulin levels also to be
high, and so the system will burn glucose at a much faster rate than fatty acids, leading
to high levels of SW , that is, values near one. However, when glucose levels fall, we
also expect insulin to return to its level of the fasted state, and fatty acid oxidation will
then dominate, leading to small values of SW . The magnitude of the switch between
the highest level of SW and the lowest is a measure of flexibility. In insulin insensitive
individuals, we expect to observe considerable fatty acid oxidation even when glucose
levels are high, leading to a lower maximum value of SW than in insulin-sensitive ones.
Experimentally, metabolic flexibility is measured using ΔRQ|clamp measurements. The
respiratory quotient (RQ) is the ratio of CO2 production to O2 consumption. Under
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conditions of entirely carbohydrate oxidation, RQ = 1, whereas pure fatty acid oxidation
yields RQ = 0.71; (these figures ignore protein and amino acid oxidation). A dose of
insulin will cause a rise in RQ as it allows glucose to be oxidised. The rise in RQ is
recorded as ΔRQ. RQ can exceed unity, if respiration is accompanied by the conversion
of carbohydrates into fats, and RQ can drop below 0.7 in starvation.
3 Results of numerical simulations
The results of our numerical simulations are illustrated in Figures 2 – 4. Due to the
current lack of data for parameters, all graphs show nondimensional quantities, in which
concentrations are measured in multiples of their steady-state values in the fasted state.
However, it is useful to note the timescales of interest. The timescales are chosen to
illustrate both the kinetics of the short-term post-prandial state, and the longer-term
return to the fasted state which occurs over several hours. From (26) we know that one
hour corresponds to nondimensional time unit of βG/αG
∗
b. We take data from an average
human male, weighing 70kg, and having 4.5 litres of blood. Now α = 1/6 (dimensionless),
G∗b = 85 mg / dl (Table 2) giving G
∗
b =3885 mg per person, and βG = 2.7 mg/kg/min
which is equivalent to βG = 11340 mg per person per hr. Hence t = one hour corresponds
to t̂ = 11340∗6/3885 = 17.5; t̂ = 10 corresponds to 34 minutes and t̂ = 100 to 5.7 hours.
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Figure 2: Short-timescale post-prandial kinetics. All nondimensional concentrations are
plotted against time, on left: unconstrained ranges on the vertical axis; on right, vertical
axis constrained to 0 ≤ x ≤ 2 to show more clearly the behaviour near to the steady-
state. A nondimensional time of t̂ = 10 corresponds to 34 minutes.
Figure 2 shows that over the short time-scale of a few minutes the blood glucose and
insulin levels rise in response to the carbohydrate in the meal. Whilst the blood glucose
concentration drops back and below its steady-state level, the insulin level remains
elevated since it also responds to the fatty acid which, along with the triglycerides, enters
the blood plasma over a timescale of about an hour. The muscle glucose (Gm) and muscle
fatty acid (Am) concentrations follow the plasma glucose (Gb) and plasma fatty acid (Ab)
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ones respectively, both being delayed versions and showing a lower amplitude. For the
parameter values used here we see little deviation of the glycogen concentration (Ym)
from its steady value.
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Figure 3: Longer-term post-prandial kinetics, showing return to the fasted steady-state.
All nondimensional concentrations are plotted against time. Left: unconstrained ranges
on the vertical axis; right: vertical axis constrained to 0 ≤ x ≤ 2 to show more clearly
the behaviour near to the steady-state. A nondimensional time of t̂ = 100 corresponds
to 5.7 hours.
The right-hand graph in Figure 2 shows P oscillating first in response to the glucose spike
and later in response to the fatty acid surge. The longer-term dynamics as the system
returns to its steady-state are shown in Figure 3. The switching variable SW defined in
(45) is the proportion of P which is oxidised by glucose (the bottom left-hand pathway
in Figure 1) as opposed to the fatty-acid pathway (bottom right). The dependence of
SW on insulin sensitivity is analysed in more detail in the next section.
3.1 Examples of insulin sensitivity
We show that by varying some of the parameters so as to more closely reflect a patient
with diabetes, via the associated insensitivity to insulin, we obtain less dramatic changes
in the switching parameter. This is performed by varying the parameter σ which, from
Table 3, influences the values of β4, β6, β7, ψa, ψT , 
g, 
y, 
p, 
i in equations (30)–(37).
The results are shown in Figure 4. For σ = 1, corresponding to normal insulin sensitivity,
we see a rapid rise as glucose oxidation predominates (when −1 < log t < 0 corresponding
to 1–5 minutes); over longer times (when 2 < log t < 3, corresponding to 30–60
minutes), we observe a severe dip as all oxidation is of fatty acids, followed by a slow
return to steady-state where both glucose and fatty acids are being oxidised. A similar
curve is observed for the case σ = 10, which models the (hypothetical) case of insulin
supersensitivity. The only differences are that the peak and trough occur slightly earlier
than the case σ = 1. When we analyse the insulin insensitive case, where σ = 0.1 or 0.3,
we observe a dramatic reduction in the height of the peak and a delay in its position
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(in time); also we note that the subsequent trough is the greatly reduced in depth,
occurs later in time, and is extended in duration. During the period 2 < log t < 5,
which corresponds to 30 minutes–8.5 hours, there is only a small shift towards fatty-acid
oxidation. To summarise, insulin-insensitivity causes the proportion of glucose and fatty
acid oxidation to change very little in time: there is no dominance of glucose oxidation
shortly after eating, and no switch to predominantly fatty acid oxidation at later times.
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Figure 4: Plot of SW against log(t) showing the effect of varying the insulin sensitivity,
σ on the fuel switching variable SW (45). The solid line corresponds to σ = 1, the
normal case; the dotted line corresponds to the insulin super-sensitive case σ = 10; the
dash-dotted line to insulin insensitive case where σ = 0.3, and the dashed line to the
case of extreme insulin insensitivity where σ = 0.1.
Ukropcova et al. [14] show fairly noisy data from the results of measurements from
patients. Figure 3 of [14] plots metabolic flexibility, insulin sensitivity, body fat, and
fasted insulin levels against in vitro adaptability. From these it is possible to construct a
graph of metabolic flexibility against fasting insulin level which we could compare to our
model results. Metabolic flexibility is then measured by ΔRQ|clamp, that is, the change
in respiratory quotient, or the difference in glucose oxidation between fed and fasted
states.
4 Conclusions
We have developed a model which exhibits switching of oxidation between glucose
and fat in accordance with insulin levels as a natural consequence of the system’s
dynamics, without the need for an artificial switching term. Simulations using this
model qualitatively reproduce experimental observations of the evolution of glucose and
fat levels in blood and muscle tissue following a meal.
Appropriate future work includes:
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• the need to address the role of whatever enzymes or hormones control the transport
of triglycerides from the blood into fatty acids in the cell;
• a more precise description of what P stands for, whether it is AMP, or an
enzyme/hormone which controls the oxidation pathway;
• finding parameter values from the literature;
• validating the model against experimental data from the literature, e.g. Ukropcova
et al. [14], (determining how ΔRQ|clamp depends on our model variables);
• possibly including a triglyceride store for fat within the cell;
• reformulating the model in terms of calorific content rather than concentrations.
This would allow a more straightforward comparison of the relative effects of
glucose and fat oxidation.
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